Lantern Pharma Inc. Prepaid Expense and Other Assets, Noncurrent
Lantern Pharma Inc. (LTRN) had Prepaid Expense and Other Assets, Noncurrent of $1.11 million as of 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Notes
us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent · last filed 2021-05-03
- 2021-03-31: Prepaid Expense and Other Assets, Noncurrent $1.11M.
- 2020-12-31: Prepaid Expense and Other Assets, Noncurrent $1.01M.
- 2020-09-30: Prepaid Expense and Other Assets, Noncurrent $1.67M.
| Period end | Prepaid Expense and Other Assets, Noncurrent |
|---|---|
| 2021-03-31 | $1.11M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $1.01M 10-K · filed 2021-03-10 |
| 2020-09-30 | $1.67M 10-Q · filed 2020-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |